IDREMLI Trademark

Trademark Overview

On Tuesday, January 25, 2022, a trademark application was filed for IDREMLI with the United States Patent and Trademark Office. The USPTO has given the IDREMLI trademark a serial number of 97237145. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, July 9, 2024. This trademark is owned by Merck Sharp & Dohme Corp.. The IDREMLI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, anti-infectives and antivirals
idremli

General Information

Serial Number97237145
Word MarkIDREMLI
Filing DateTuesday, January 25, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, anti-infectives and antivirals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMERCK SHARP & DOHME LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065
Party NameMERCK SHARP & DOHME LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressRAHWAY, NJ 07065
Party NameMerck Sharp & Dohme Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889

Trademark Events

Event DateEvent Description
Friday, January 28, 2022NEW APPLICATION ENTERED
Friday, January 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 29, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, November 3, 2022ASSIGNED TO EXAMINER
Wednesday, November 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 19, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 19, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 19, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, August 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 31, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 31, 2023SOU EXTENSION 1 FILED
Monday, July 31, 2023SOU EXTENSION 1 GRANTED
Wednesday, January 3, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, January 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024SOU EXTENSION 3 GRANTED
Tuesday, July 9, 2024SOU EXTENSION 3 FILED
Tuesday, January 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 12, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 12, 2024SOU EXTENSION 2 FILED
Friday, January 12, 2024SOU EXTENSION 2 GRANTED

Related Keywords

idremli infectives antivirals anti namely preparations pharmaceutical